Heterogeneity of Gestational Diabetes and Risk for Adverse Pregnancy Outcome: A Cohort Study

被引:0
|
作者
Gong, Yixin [1 ]
Wang, Qunhua [2 ]
Chen, Suyu [2 ]
Liu, Yujie [2 ]
Li, Chenghua
Kang, Rong [1 ,3 ]
Wang, Jing [1 ]
Wei, Tian [1 ]
Wang, Qin [1 ]
Li, Xianming [1 ]
Luo, Sihui [1 ]
Weng, Jianping [1 ]
Zheng, Xueying [1 ]
Ding, Yu [1 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Endocrinol, Div Life Sci & Med, Hefei 230001, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Obstet & Gynecol, Hefei 230001, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Cardiol, Div Life Sci & Med, Hefei 230001, Peoples R China
关键词
gestational diabetes; heterogeneity; insulin resistance; pregnancy outcomes; GLUCOSE-TOLERANCE; FASTING HYPERGLYCEMIA; INSULIN-RESISTANCE; MELLITUS; PATHOGENESIS; WOMEN; LIVER;
D O I
10.1210/clinem/dgae754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Diabetes is increasingly recognized as a heterogeneous disease, with clinical characteristics and outcome risks varying across different phenotypes. Evidence on heterogeneity of gestational diabetes (GDM) is yet to be provided. Objective: To investigate the insulin physiology and pregnancy outcomes of GDM phenotypes characterized by fasting hyperglycemia or postload hyperglycemia. Methods: A total of 2050 women who underwent a 75-g oral glucose tolerance test were prospectively recruited and followed until delivery. Women were categorized into normoglycemia (NGT, n = 936), isolated impaired fasting glucose (gestational-IFG, n = 378), and isolated impaired postload glucose tolerance (gestational-IGT, n = 736) groups. Fasting blood samples at mid-pregnancy were collected to measure C-peptide and insulin concentrations. Homeostasis model assessment (HOMA) and quantitative insulin sensitivity check index (QUICKI) were used to evaluate insulin physiology. Maternal and neonatal outcomes were recorded. Results: Gestational-IFG had greater insulin resistance (HOMA-IR 3.11 vs 2.25, QUICKI-C-peptide 0.94 vs 1.03, both P < .01), and gestationalIGT had worse (3-cell function (C-peptide 2.00 vs 2.26 ng/mL, P < .05), when compared to one another. Gestational-IFG was more strongly associated with excessive gestational weight gain (risk ratio ERR] 1.62; 95% CI, 1.18-2.23) and large-for-gestational-age infants (RR 1.45; 95% CI, 1.03-2.03) than gestational-IGT. The risk for neonatal brain injury was increased in gestational-IGT (RR 2.03; 95% CI, 1.04-4.09), but not in gestational-IFG (P = .439). Gestational-IGT showed a stronger association with the risk of preterm birth compared to gestational-IFG (RR 1.80; 95% CI, 1.02-3.36). Conclusion: GDM exhibits distinct insulin physiology profiles. Pregnancy outcome varies between each phenotype. These findings provide evidence on risk stratification and diverse strategies for the treatment of GDM.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Gestational weight gain and adverse pregnancy outcomes: a prospective cohort study
    Wu, Yuelin
    Wan, Sheng
    Gu, Shengyi
    Mou, Zhengqian
    Dong, Lingling
    Luo, Zhongcheng
    Zhang, Jun
    Hua, Xiaolin
    BMJ OPEN, 2020, 10 (09):
  • [32] People with diabetes and unmonitored renal function are at increased risk of an adverse outcome: a cohort study
    Mcgovern, A. P.
    Rusholme, B.
    de Lusignan, S.
    van Vlymen, J.
    Jones, S.
    DIABETIC MEDICINE, 2013, 30 : 28 - 29
  • [33] Associations of Gestational Lipids and Apolipoproteins With Pregnancy Outcomes: The Hyperglycemia and Adverse Pregnancy Outcome Study
    Perak, Amanda M.
    Kuang, Alan
    Lancki, Nicola
    Labarthe, Darwin R.
    Shah, Svati H.
    Lowe, Lynn
    Wilkins, John T.
    Lowe, William
    Lloyd-Jones, Donald M.
    Scholtens, Denise
    CIRCULATION, 2020, 141
  • [34] Associations of gestational cardiovascular health with pregnancy outcomes: the Hyperglycemia and Adverse Pregnancy Outcome study
    Perak, Amanda M.
    Lancki, Nicola
    Kuang, Alan
    Labarthe, Darwin R.
    Allen, Norrina B.
    Shah, Svati H.
    Lowe, Lynn P.
    Grobman, William A.
    Scholtens, Denise M.
    Lloyd-Jones, Donald M.
    Lowe, William L., Jr.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02)
  • [35] Associations of Gestational Cardiovascular Health With Pregnancy Outcomes: The Hyperglycemia and Adverse Pregnancy Outcome Study
    Perak, Amanda M.
    Lancki, Nicola
    Kuang, Alan
    Labarthe, Darwin R.
    Shah, Svati H.
    Lowe, Lynn
    Scholtens, Denise
    Lloyd-Jones, Donald M.
    Lowe, William
    CIRCULATION, 2020, 141
  • [36] Update on gestational diabetes and adverse pregnancy outcomes
    Ugwudike, Bryan
    Kwok, Manho
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2023, 35 (05) : 453 - 459
  • [37] Pre-pregnancy potato consumption and risk of gestational diabetes mellitus: prospective cohort study
    Bao, Wei
    Tobias, Deirdre K.
    Hu, Frank B.
    Chavarro, Jorge E.
    Zhang, Cuilin
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [38] Combined healthy lifestyle in early pregnancy and risk of gestational diabetes mellitus: A prospective cohort study
    Wu, L.
    Ouyang, J.
    Lai, Y.
    Wu, P.
    Wang, Y.
    Ye, Y.
    Wang, J.
    Hu, M.
    Zhang, J.
    Xu, J.
    Yang, X.
    Yuan, J.
    Zhao, B.
    Song, X.
    Yan, S.
    Lv, C.
    Liu, G.
    Pan, A.
    Pan, X. -F
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (13) : 1611 - 1619
  • [39] Protein powder supplementation in early pregnancy and the risk of gestational diabetes mellitus: a prospective cohort study
    Yang, Meng
    Cao, Zhongqiang
    Zhou, Jieqiong
    Liu, Jiuying
    Zhong, Yuanyuan
    Zhou, Yan
    Cai, Xiaonan
    Yu, Linling
    Hu, Liqin
    Xiao, Han
    Zhou, Aifen
    FOOD & FUNCTION, 2023, 14 (08) : 3815 - 3823
  • [40] Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial/ethnic cohort
    Rahman, Mohammad L.
    Feng, Yen-Chen A.
    Fiehn, Oliver
    Albert, Paul S.
    Tsai, Michael Y.
    Zhu, Yeyi
    Wang, Xiaobin
    Tekola-Ayele, Fasil
    Liang, Liming
    Zhang, Cuilin
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)